This FAQ is taken from Flow matters COVID-19 edition, updated Feb 2022. Read the complete edition here.
Nasal high flow use on COVID-19 patients has been observed to:
“[NHF] use is associated with a reduction in the rate of invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.” - Patel et al. 2020.
The number of organizations that have published evidence-based guidelines recommending the use of NHF for COVID-19 patients continues to grow:
You might also be interested in:
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment